Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
AVAH vs PNTG vs ADUS vs HCSG vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
AVAH vs PNTG vs ADUS vs HCSG vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $1.46B | $1.24B | $1.81B | $1.60B | $10.18B |
| Revenue (TTM) | $2.43B | $1.02B | $1.45B | $1.84B | $5.27B |
| Net Income (TTM) | $225M | $30M | $100M | $59M | $363M |
| Gross Margin | 33.1% | 11.1% | 32.5% | 13.3% | 15.2% |
| Operating Margin | 10.9% | 5.6% | 9.8% | 3.0% | 8.5% |
| Forward P/E | 12.0x | 27.0x | 14.1x | 20.8x | 23.2x |
| Total Debt | $1.34B | $453M | $209M | $25M | $4.15B |
| Cash & Equiv. | $193M | $17M | $82M | $161M | $504M |
AVAH vs PNTG vs ADUS vs HCSG vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Aveanna Healthcare … (AVAH) | 100 | 59.4 | -40.6% |
| The Pennant Group, … (PNTG) | 100 | 88.4 | -11.6% |
| Addus HomeCare Corp… (ADUS) | 100 | 92.0 | -8.0% |
| Healthcare Services… (HCSG) | 100 | 74.5 | -25.5% |
| The Ensign Group, I… (ENSG) | 100 | 203.0 | +103.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVAH vs PNTG vs ADUS vs HCSG vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVAH carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (12.0x vs 23.2x)
- 9.2% margin vs PNTG's 3.0%
- 12.4% ROA vs PNTG's 3.5%, ROIC 15.1% vs 5.6%
PNTG ranks third and is worth considering specifically for growth exposure.
- Rev growth 36.3%, EPS growth 18.3%, 3Y rev CAGR 26.0%
- 36.3% revenue growth vs HCSG's 7.1%
ADUS is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.58, Low D/E 19.2%, current ratio 1.80x
- PEG 0.70 vs PNTG's 2.68
HCSG is the clearest fit if your priority is momentum.
- +55.8% vs ADUS's -13.4%
ENSG is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- 7.5% 10Y total return vs ADUS's 399.9%
- Beta 0.42, yield 0.1%, current ratio 1.42x
- Beta 0.42 vs AVAH's 1.40, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.3% revenue growth vs HCSG's 7.1% | |
| Value | Lower P/E (12.0x vs 23.2x) | |
| Quality / Margins | 9.2% margin vs PNTG's 3.0% | |
| Stability / Safety | Beta 0.42 vs AVAH's 1.40, lower leverage | |
| Dividends | 0.1% yield; 12-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +55.8% vs ADUS's -13.4% | |
| Efficiency (ROA) | 12.4% ROA vs PNTG's 3.5%, ROIC 15.1% vs 5.6% |
AVAH vs PNTG vs ADUS vs HCSG vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVAH vs PNTG vs ADUS vs HCSG vs ENSG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVAH leads in 2 of 6 categories
HCSG leads 1 • PNTG leads 0 • ADUS leads 0 • ENSG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVAH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 5.2x PNTG's $1.0B. AVAH is the more profitable business, keeping 9.2% of every revenue dollar as net income compared to PNTG's 3.0%. On growth, PNTG holds the edge at +36.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.4B | $1.0B | $1.4B | $1.8B | $5.3B |
| EBITDAEarnings before interest/tax | $289M | $66M | $159M | $72M | $558M |
| Net IncomeAfter-tax profit | $225M | $30M | $100M | $59M | $363M |
| Free Cash FlowCash after capex | $126M | $47M | $137M | $139M | $406M |
| Gross MarginGross profit ÷ Revenue | +33.1% | +11.1% | +32.5% | +13.3% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +10.9% | +5.6% | +9.8% | +3.0% | +8.5% |
| Net MarginNet income ÷ Revenue | +9.2% | +3.0% | +6.9% | +3.2% | +6.9% |
| FCF MarginFCF ÷ Revenue | +5.2% | +4.6% | +9.5% | +7.6% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.4% | +36.0% | +7.7% | +6.6% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.9% | +9.1% | +17.2% | +175.0% | +21.9% |
Valuation Metrics
AVAH leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 6.6x trailing earnings, AVAH trades at a 84% valuation discount to PNTG's 42.5x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs PNTG's 4.23x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.5B | $1.2B | $1.8B | $1.6B | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $1.7B | $1.9B | $1.5B | $13.8B |
| Trailing P/EPrice ÷ TTM EPS | 6.61x | 42.54x | 18.67x | 27.54x | 29.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.96x | 26.97x | 14.12x | 20.83x | 23.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.23x | 0.93x | — | 2.16x |
| EV / EBITDAEnterprise value multiple | 9.04x | 27.97x | 12.52x | 22.38x | 25.71x |
| Price / SalesMarket cap ÷ Revenue | 0.60x | 1.31x | 1.28x | 0.87x | 2.01x |
| Price / BookPrice ÷ Book value/share | 7.67x | 3.37x | 1.65x | 3.19x | 4.59x |
| Price / FCFMarket cap ÷ FCF | 11.63x | 47.16x | 17.48x | 11.49x | 27.46x |
Profitability & Efficiency
Evenly matched — AVAH and HCSG each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
AVAH delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $8 for PNTG. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVAH's 6.91x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs PNTG's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.5% | +8.4% | +9.3% | +11.8% | +16.6% |
| ROA (TTM)Return on assets | +12.4% | +3.5% | +7.0% | +7.3% | +6.8% |
| ROICReturn on invested capital | +15.1% | +5.6% | +8.8% | +9.0% | +7.0% |
| ROCEReturn on capital employed | +18.6% | +7.3% | +10.9% | +7.7% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 6.91x | 1.21x | 0.19x | 0.05x | 1.86x |
| Net DebtTotal debt minus cash | $1.2B | $436M | $127M | -$136M | $3.7B |
| Cash & Equiv.Liquid assets | $193M | $17M | $82M | $161M | $504M |
| Total DebtShort + long-term debt | $1.3B | $453M | $209M | $25M | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 1.79x | 16.52x | 14.45x | 33.02x | 88.33x |
Total Returns (Dividends Reinvested)
Evenly matched — AVAH and HCSG and ENSG each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $6,019 for AVAH. Over the past 12 months, HCSG leads with a +55.8% total return vs ADUS's -13.4%. The 3-year compound annual growth rate (CAGR) favors AVAH at 89.5% vs ADUS's 5.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.1% | +28.4% | -8.7% | +28.6% | +0.3% |
| 1-Year ReturnPast 12 months | +44.0% | +28.7% | -13.4% | +55.8% | +27.5% |
| 3-Year ReturnCumulative with dividends | +580.4% | +204.1% | +16.3% | +48.6% | +88.9% |
| 5-Year ReturnCumulative with dividends | -39.8% | -6.9% | +0.0% | -21.1% | +103.2% |
| 10-Year ReturnCumulative with dividends | -42.2% | +136.8% | +399.9% | -26.8% | +752.0% |
| CAGR (3Y)Annualised 3-year return | +89.5% | +44.9% | +5.2% | +14.1% | +23.6% |
Risk & Volatility
Evenly matched — PNTG and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than AVAH's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PNTG currently trades 99.7% from its 52-week high vs AVAH's 67.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 0.79x | 0.58x | 1.12x | 0.42x |
| 52-Week HighHighest price in past year | $10.32 | $35.84 | $124.44 | $24.39 | $218.00 |
| 52-Week LowLowest price in past year | $3.73 | $21.73 | $90.89 | $12.66 | $133.81 |
| % of 52W HighCurrent price vs 52-week peak | +67.2% | +99.7% | +78.2% | +91.5% | +80.0% |
| RSI (14)Momentum oscillator 0–100 | 53.4 | 62.5 | 49.3 | 61.8 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 245K | 236K | 676K | 358K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AVAH as "Hold", PNTG as "Buy", ADUS as "Buy", HCSG as "Hold", ENSG as "Buy". Consensus price targets imply 58.5% upside for AVAH (target: $11) vs 9.2% for PNTG (target: $39). ENSG is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $11.00 | $39.00 | $128.67 | $24.50 | $222.33 |
| # AnalystsCovering analysts | 12 | 7 | 15 | 15 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.1% |
| Dividend StreakConsecutive years of raises | — | 1 | 2 | 20 | 12 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +3.9% | +0.2% |
AVAH leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). HCSG leads in 1 (Analyst Outlook). 3 tied.
AVAH vs PNTG vs ADUS vs HCSG vs ENSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVAH or PNTG or ADUS or HCSG or ENSG a better buy right now?
For growth investors, The Pennant Group, Inc.
(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus 7. 1% for Healthcare Services Group, Inc. (HCSG). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 6x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate The Pennant Group, Inc. (PNTG) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVAH or PNTG or ADUS or HCSG or ENSG?
On trailing P/E, Aveanna Healthcare Holdings Inc.
(AVAH) is the cheapest at 6. 6x versus The Pennant Group, Inc. at 42. 5x. On forward P/E, Aveanna Healthcare Holdings Inc. is actually cheaper at 12. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Pennant Group, Inc. 's 2. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — AVAH or PNTG or ADUS or HCSG or ENSG?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -39. 8% for Aveanna Healthcare Holdings Inc. (AVAH). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus AVAH's -42. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVAH or PNTG or ADUS or HCSG or ENSG?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Aveanna Healthcare Holdings Inc. 's 1. 40β — meaning AVAH is approximately 232% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AVAH or PNTG or ADUS or HCSG or ENSG?
By revenue growth (latest reported year), The Pennant Group, Inc.
(PNTG) is pulling ahead at 36. 3% versus 7. 1% for Healthcare Services Group, Inc. (HCSG). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVAH or PNTG or ADUS or HCSG or ENSG?
Aveanna Healthcare Holdings Inc.
(AVAH) is the more profitable company, earning 9. 2% net margin versus 3. 1% for The Pennant Group, Inc. — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAH leads at 10. 9% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — AVAH leads at 33. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVAH or PNTG or ADUS or HCSG or ENSG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Pennant Group, Inc. 's 2. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Aveanna Healthcare Holdings Inc. (AVAH) trades at 12. 0x forward P/E versus 27. 0x for The Pennant Group, Inc. — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVAH: 58. 5% to $11. 00.
08Which pays a better dividend — AVAH or PNTG or ADUS or HCSG or ENSG?
In this comparison, ENSG (0.
1% yield) pays a dividend. AVAH, PNTG, ADUS, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is AVAH or PNTG or ADUS or HCSG or ENSG better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, AVAH: -42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVAH and PNTG and ADUS and HCSG and ENSG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AVAH is a small-cap high-growth stock; PNTG is a small-cap high-growth stock; ADUS is a small-cap high-growth stock; HCSG is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.